SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of the International Association of Physicians in AIDS Care (JIAPAC)
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Loupa, C. V.
Right arrow Articles by Rodríguez, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loupa, C. V.
Right arrow Articles by Rodríguez, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

New Entrants to HIV Care Are Presenting Only at Marginally Earlier Stages of Disease but May Increasingly Represent Groups Perceived at Lower Risk

Chariclia V. Loupa, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Michael M. Lederman, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Hernán Valdez, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgebury, Conn

Robert A. Salata, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Grace A. McComsey, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Barbara Gripshover, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Scott Fulton, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Michelle V. Lisgaris, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Michelle Kucia

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Robert Asaad, MD

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Jennifer Cline

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio

Benigno Rodríguez, MD, MSc

Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio, Rodriguez.benigno{at}clevelandactu.org

Background : Treatment has improved HIV infection prognosis, but whether risk and health care seeking behavior have improved is unclear. Methods: New entrants to HIV care at University Hospitals of Cleveland, Ohio, between 1995 and 2002, with no history of AIDS-defining illnesses or antiretroviral exposure were included. Results: Of new patients, 806 (80%) met the inclusion criteria. Median age increased during the study period(35.2 to 38.6 years; P < .001); proportions of females and non-whites increased nonsignificantly. Prevalence of AIDS-defining illnesses decreased from 1995 to 1996 (25.0% to 14.2%; P <.001) but remained stable thereafter. Category B conditions and sexually transmitted diseases decreased significantly(31.7% to 9.1%; P = .039 and 22.5% to 8.0%; P = .003), as did hepatitis B and C seroprevalence (8.3% to 3.6%; P = .05 and 26.2% to 14.3%; P = .003). Median CD4 counts and HIV RNA did not change significantly. Conclusions: Prevalence of Category B conditions, sexually transmitted diseases, and hepatitis B and C declined significantly in this study. Prevalence of AIDS-defining illnesses decreased early in the highly active antiretroviral therapy era only, whereas markers of HIV disease stage remained stable, suggesting a need for earlier recognition of infection. Decreasing sexually transmitted diseases and hepatitis coinfections suggest that HIV infection is increasingly seen in populations previously perceived at lower risk.

Key Words: HIV infection • HIV testing • HIV epidemiology • viral hepatitis

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 4, No. 2, 47-51 (2005)
DOI: 10.1177/1545109705278112


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement